拜耳中风药 asundexian 获美国批准，制药业务迎来利好
Bayer won US approval for stroke drug asundexian, bolstering the German company’s pharmaceutical unit as some of its biggest medicines face generic c...
AI 导读
拜耳的中风药物 asundexian 获得美国监管批准，为这家德国公司的制药业务提供支撑。此前，拜耳多款重磅药物正面临仿制药竞争的压力。